Home / Import refusals / SCS-1316175-9/71/1

FDA Import Refusal SCS-1316175-9/71/1 — Taisho Pharmaceutical Co., Ltd.

Taisho Pharmaceutical Co., Ltd. — FEI 6873

The FDA refused shipment SCS-1316175-9/71/1 from Taisho Pharmaceutical Co., Ltd. (Japan) on August 20, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
August 20, 2020
Country
Japan
Product Category
Drugs and Biologics
Product Code
66VAY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
118,3280

Other import refusals

  • 799-3709683-2/11/1 (Wed Mar 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-3383332-9/11/1 (Fri Feb 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0174291-6/11/1 (Wed Jul 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8229756-4/11/1 (Wed Aug 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7538629-1/11/1 (Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources